东诚药业：关于全资子公司药品达肝素钠注射液增加规格获批上市的公告

Core Viewpoint - Dongcheng Pharmaceutical has received approval from the National Medical Products Administration for a new specification of its heparin sodium injection, indicating a positive development for the company's product portfolio [1] Group 1 - Dongcheng Pharmaceutical's wholly-owned subsidiary, Yantai Dongcheng Northern Pharmaceutical Co., Ltd., has been notified of the approval for the new specification (0.2ml: 5000AXaIU) of heparin sodium injection [1]